Your browser doesn't support javascript.
loading
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
Sakemura, R Leo; Hefazi, Mehrdad; Cox, Michelle J; Siegler, Elizabeth L; Sinha, Sutapa; Hansen, Michael J; Stewart, Carli M; Feigin, Jennifer M; Manriquez Roman, Claudia; Schick, Kendall J; Can, Ismail; Tapper, Erin E; Horvei, Paulina; Adada, Mohamad M; Bezerra, Evandro D; Kankeu Fonkoua, Lionel Aurelien; Ruff, Michael W; Forsman, Cynthia L; Nevala, Wendy K; Boysen, Justin C; Tschumper, Renee C; Grand, Cory L; Kuchimanchi, Kameswara R; Mouritsen, Lars; Foulks, Jason M; Warner, Steven L; Call, Timothy G; Parikh, Sameer A; Ding, Wei; Kay, Neil E; Kenderian, Saad S.
Affiliation
  • Sakemura RL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Hefazi M; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Cox MJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Siegler EL; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Sinha S; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Hansen MJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Stewart CM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Feigin JM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Manriquez Roman C; Department of Immunology, Mayo Clinic, Rochester, Minnesota.
  • Schick KJ; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Can I; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Tapper EE; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Horvei P; Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota.
  • Adada MM; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Bezerra ED; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Kankeu Fonkoua LA; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Ruff MW; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota.
  • Forsman CL; Department of Molecular Medicine, Mayo Clinic, Rochester, Minnesota.
  • Nevala WK; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Boysen JC; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Tschumper RC; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Grand CL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Kuchimanchi KR; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Mouritsen L; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Foulks JM; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Warner SL; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Call TG; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Parikh SA; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Ding W; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
  • Kay NE; Department of Neurology, Mayo Clinic, Rochester, Minnesota.
  • Kenderian SS; T Cell Engineering, Mayo Clinic, Rochester, Minnesota.
Cancer Immunol Res ; 11(9): 1222-1236, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37378662
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Chimeric Antigen / Neoplasms Limits: Humans Language: En Journal: Cancer Immunol Res Year: 2023 Document type: Article Country of publication: Estados Unidos